[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Sentiment: XX%
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XXX% +40%
1 Month: XX% no change
6 Months: XX% +19%
1 Year: XX% -X%
1-Year High: XXX% on 2024-10-18
1-Year Low: XX% on 2025-08-02
Most Supportive Themes
- Positive Developments and Investments: (40%) Roche is making significant investments and announcements, including expanding its manufacturing hub and building new facilities.
- Positive Sentiment and Engagement: (30%) The sentiment around $rhhby is up, with increased mentions and engagements across social networks.
- Alnylam Partnership and Zilebesiran: (20%) The partnership with Alnylam and the advancement of Zilebesiran into a Phase X cardiovascular outcomes trial is viewed positively.
Most Critical Themes
- Potential Cancer Risk with GLP-1RA: (10%) Some posts discuss a potential link between long-term GLP-1RA use and increased cancer risk, particularly for women.
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| X | XXXXX | XX% | XXXXX | XX% | X | X% |
| Total | XXXXX | XX% | XXXXX | XX% | X | X% |